Physician profile
Ron E Kastner
NPI 1134200058
$2,485.99
in general payments reported to CMS, 2019-2025
33 companies · $627 in 2025
The $627 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.58 · 2020: $340 · 2021: $333 · 2022: $354 · 2023: $82.73 · 2024: $686 · 2025: $627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,395.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $296.56 | 2020-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Pfizer INC. | $294.28 | 2019-2025 | |
| Novo Nordisk INC | $270.06 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $197.78 | 2020-2024 | |
| Glaxosmithkline, LLC. | $186.87 | 2020-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $155.70 | 2020-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $146.38 | 2022-2025 | Eliquis, Camzyos |
| Abbvie INC. | $134.86 | 2021-2025 | |
| Amgen INC. | $118.12 | 2021-2025 | Otezla, Repatha, Repatha |
| Amarin Pharma, INC. | $64.18 | 2020-2021 | |
| Axsome Therapeutics, INC. | $56.57 | 2025 | Symbravo |
| Genzyme Corporation | $49.72 | 2024-2025 | |
| Inspire Medical Systems, INC. | $49.31 | 2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $43.74 | 2020-2021 | |
| Edwards Lifesciences Corporation | $40.22 | 2024 | Sapien 3 Ultra Resilia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.87 | 2025 | Spravato |
| Irhythm Technologies, INC. | $29.59 | 2024 | Zio Xt Patch, Zio Monitor |
| Tactile Systems Technology INC | $28.47 | 2025 | Nimbl, Flexitouch Plus |
| Gilead Sciences, INC. | $24.96 | 2021 | |
| Exact Sciences Corporation | $23.71 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $23.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.84 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $21.17 | 2022 | |
| Medicomp INC | $21.08 | 2025 | Telepatch Cardiac Monitor |
| Regeneron Healthcare Solutions, INC. | $20.30 | 2025 | Dupixent |
| Otsuka America Pharmaceutical, INC. | $19.37 | 2025 | Rexulti |
| Lilly USA, LLC | $19.21 | 2024 | Jardiance, Zepbound |
| Insightec,INC | $17.48 | 2025 | Exablate |
| Astellas Pharma US INC | $16.67 | 2025 | Veozah |
| Boston Scientific Corporation | $15.53 | 2019 | |
| Genentech USA, INC. | $14.70 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $14.62 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Kastner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.